Early cancer detection often leads to less aggressive treatments, reduced recovery times and higher survival rates.

but FDA approval will help broaden availability and insurance coverage. The test was approved for people aged 45 and older with an "average risk" of colon cancer. Specialists warn that the blood ...

Detecting the cancerous DNA fragments released into the bloodstream can detect the presence ... currently the second blood test to screen for colon cancer. In 2016, the FDA approved Epigenomics ...

The Food and Drug Administration approved a blood ... FDA’s approval, Medicare and private insurance companies are more likely to cover the test’s $895 cost. It comes at a time when colorectal ...

The Food and Drug Administration approved a blood test intended ... for catching colon cancer early. "The gold standard for colon cancer screening is colonoscopy because it can detect colon ...